Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Sunnybrook Health Sciences Centre

Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada is listed as a site for 810 registered clinical trials, 233 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 810
Ongoing 233

This page covers the site record Sunnybrook Health Sciences Centre in Toronto, Ontario, Canada: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Sunnybrook Health Sciences Centre report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 810 trials counted.

  • Phase 1 30 trials
  • Phase 1/2 15 trials
  • Phase 2 100 trials
  • Phase 2/3 24 trials
  • Phase 3 153 trials
  • Phase 4 31 trials
  • Not applicable 332 trials
  • Observational 124 trials
  • Expanded access 1 trial

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 233 trials
  • Completed 372 trials
  • Terminated 90 trials
  • Other 115 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 55

1995: 1 trials (Observational 1) 2001: 2 trials (Phase 3 2) 2002: 4 trials (Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1/2 1) 2003: 2 trials (Phase 4 2) 2004: 4 trials (Not applicable 3, Phase 3 1) 2005: 6 trials (Not applicable 1, Phase 4 2, Phase 3 2, Phase 2 1) 2006: 24 trials (Observational 4, Not applicable 7, Phase 4 4, Phase 3 4, Phase 2/3 1, Phase 2 1, Phase 1 3) 2007: 21 trials (Observational 5, Not applicable 5, Phase 4 1, Phase 3 7, Phase 2/3 1, Phase 2 2) 2008: 21 trials (Observational 4, Not applicable 5, Phase 4 3, Phase 3 3, Phase 2/3 1, Phase 2 4, Phase 1 1) 2009: 28 trials (Observational 7, Not applicable 7, Phase 4 2, Phase 3 4, Phase 2 4, Phase 1/2 1, Phase 1 3) 2010: 31 trials (Observational 5, Not applicable 9, Phase 4 2, Phase 3 9, Phase 2 4, Phase 1/2 1, Phase 1 1) 2011: 43 trials (Observational 8, Not applicable 14, Phase 4 1, Phase 3 11, Phase 2/3 2, Phase 2 5, Phase 1/2 1, Phase 1 1) 2012: 30 trials (Observational 3, Not applicable 13, Phase 4 1, Phase 3 4, Phase 2/3 3, Phase 2 5, Phase 1/2 1) 2013: 28 trials (Observational 3, Not applicable 14, Phase 3 6, Phase 2/3 1, Phase 2 4) 2014: 49 trials (Observational 11, Not applicable 21, Phase 3 10, Phase 2/3 1, Phase 2 5, Phase 1/2 1) 2015: 37 trials (Observational 3, Not applicable 17, Phase 4 2, Phase 3 6, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 1) 2016: 43 trials (Observational 7, Not applicable 17, Phase 4 2, Phase 3 5, Phase 2/3 2, Phase 2 5, Phase 1/2 1, Phase 1 4) 2017: 46 trials (Observational 8, Not applicable 20, Phase 3 7, Phase 2/3 1, Phase 2 6, Phase 1/2 1, Phase 1 3) 2018: 55 trials (Observational 6, Not applicable 32, Phase 4 1, Phase 3 8, Phase 2/3 3, Phase 2 5) 2019: 52 trials (Observational 13, Not applicable 23, Phase 4 1, Phase 3 5, Phase 2/3 2, Phase 2 8) 2020: 44 trials (Observational 6, Not applicable 23, Phase 3 10, Phase 2/3 1, Phase 2 1, Phase 1/2 1, Phase 1 2) 2021: 50 trials (Observational 6, Not applicable 26, Phase 4 2, Phase 3 9, Phase 2/3 1, Phase 2 5, Phase 1/2 1) 2022: 37 trials (Observational 4, Not applicable 15, Phase 4 1, Phase 3 10, Phase 2 4, Phase 1 3) 2023: 46 trials (Observational 7, Not applicable 21, Phase 3 11, Phase 2 5, Phase 1/2 2) 2024: 36 trials (Observational 6, Not applicable 12, Phase 4 2, Phase 3 6, Phase 2/3 2, Phase 2 5, Phase 1 3) 2025: 41 trials (Observational 4, Not applicable 14, Phase 4 1, Phase 3 7, Phase 2 9, Phase 1/2 1, Phase 1 5)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 26
2025 41
2024 36
2023 46
2022 37
2021 50
2020 44
2019 52
2018 55
2017 46

Showing 10 of 27 years.

Start your 14-day trial Email me all 27 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 810 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 96 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 367 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF